Rice University has launched RBL LLC, a biotech venture creation studio, to accelerate the commercialization of medical technologies and enhance patient care.
RBL aims to develop companies focused on lifesaving medical technologies that emerge from the Rice Biotech Launch Pad. With a robust portfolio of over 100 patents from Rice faculty, RBL creates an environment where scientists, engineers, and business executives collaborate to transform research into viable companies.
Located within Houston's Texas Medical Center Helix Park, RBL bridges the gap between academic discoveries and the clinical care market, facilitating collaboration with clinical centers, corporate partners, and investors. The goal is to expedite the journey from laboratory research to patient care.
RBL was co-founded by experts in the field and reflects Houston's emergence as a global life sciences powerhouse. The initiative amplifies the work of the Rice Biotech Launch Pad and aims to create opportunities for biotech ventures statewide. RBL's mission is to translate scientific discoveries into therapies that improve patient outcomes.
By working closely with partners in the Texas Medical Center, RBL aims to make therapeutics more accessible and affordable. The formation of RBL was guided by legal expertise to navigate the complexities of the biotech landscape. RBL's establishment marks a significant step forward in Houston's biotech ecosystem and is expected to yield groundbreaking advancements in medical technology.